Shahla Ansari

Ali Asghar Children Hospital, Iran University of Medical Sciences, Tehran, Iran

[ 1 ] - Survival of Children with Germ Cell Tumors in Ali Asghar Hospital since 1990 to 2003

Background and Objective: Germ cell tumor (GCT) accounts for approximately 2-3% of all malignancies in children. In this respect, about 20% of patients with GCT are still resistant to therapy. Materials and Methods: The cross-sectional strategy of this survey was undertaken on 57 patients with germ cell ...

[ 2 ] - نامه به سردبیر

No Abstract##

[ 3 ] - Validity and Reliability Assessment of the Persian Version of Therapy-Related Symptom Checklist

AbstractTherapy-related symptom checklist for children (TRSC-C) was developed as a symptom assessment tool in children receiving chemotherapy. The objective of the present study was to evaluate the validity and reliability of the Persian version of TRSC-C. This cross-sectional study was conducted in 2013-2014 in Tehran, Iran. TRSC-C was translated using backward-forward approach. The content va...

[ 4 ] - BK Virus-Associated Hemorrhagic Cystitis in Children Suffering from Malignancies: Report of Three Cases

BK virus-associated hemorrhagic cystitis (HC) is frequent in patients undergoing bone marrow transplantation, but it rarely occurs among other immunosuppressed patients particularly in those who are receiving chemotherapy for hematologic malignancies. Herein, we report three children with malignancies suffering from hemorrhagic cystitis due to BK virus infection who were successfully improved. ...

[ 5 ] - Symptom Evaluation in Pediatric Oncology Outpatient Setting; A Cross-Sectional Study

Detection and management of cancer-related symptoms is a key component in children’s quality of life. We evaluate symptoms and their severity in Iranian pediatric oncology outpatients using Therapy-Related Symptom Checklist for Children (TRSC-C). This was a cross-sectional study conducted in two outpatient pediatric oncology settings. We included all patients aged between 5-17 years. The valida...